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Evolutionary medicine explores among other things the hu-
man vulnerability towards pathogens. To increase the diag-
nostic level of evidence, alongside radiological investigations,
molecular techniques (such as ancient DNA analyses) are
often being applied.
Ancient DNA (aDNA) is DNA recovered from archaeo-
logical and historical specimens. This DNA is highly de-
graded and fragmented by biological and environmental
factors and is therefore difficult to analyse. However,
sequences retrieved from ancient material are highly useful
in many ways, including for medical purposes.
The first aDNA experiment was conducted in 1984 to
determine the biological classification of the extinct quagga,
revealed to be a close relative of the zebra [1]. In the 1980s and
1990s there were multiple publications in which the authors
claimed to have extracted aDNA from a variety of samples.
However, some of these sequences were later determined to be
the result of modern contamination. This led to the introduc-
tion of vigorous anti-contamination procedures in the field of
aDNA research. At this time a greater understanding of the
need for hypothesis-led research allowed for a great diversity
of targets. Ancient DNA has been used extensively, for exam-
ple, to clarify the domestication events of animals and plants,
to understand the movements of humans, and to examine the
history of modern and ancient disease.
Among the first pathogens targeted by ancient DNA
researchers were the Mycobacterium tuberculosis complex
(MTBC) organisms, and this DNA has been proven to be one
of the most robust of all the pathogens studied in archaeological
remains. Tuberculosis is a chronic infection caused by any of
the members of the MTBC, which are very similar genetically.
Tuberculosis can cause numerous bone changes, most signifi-
cantly in Pott’s disease, where the vertebrae are pitted and
gradually undergo extensive osteoblastic activity, resulting in
spinal collapse, and cause a hunched posture. Whilst tubercu-
losis can be inferred from visual (including radiological) in-
spection of archaeological remains, bone changes only occur in
a minority of cases. In addition, the actual causative bacteria
cannot be known without microbiological testing.
Many groups have amplified and sequenced archaeological
MTBC DNA, and increasingly try to identify the members of
the complex; strain identification is easier than type identifi-
cation as less genetic information is required. Interestingly, so
far, only one archaeological tuberculosis case has been shown
to have been caused by the Mycobacterium bovis strain,
despite the close bovine–human habitation of the past.
Modern geneticists are increasingly studying the phylo-
geography of the MTBC, i.e. the correlation between the
strain and its location. This involves examining multiple
mutations from one sample. Traditional polymerase chain
reaction (PCR) methods work by targeting specific DNA
using primers (short pieces of nucleotides that attach to the
complimentary sequence) and copying the DNA in-
between. The DNA is then sequenced in a separate experi-
ment. Multiple primers can be used in one reaction, but
generally this only amplifies a few targets, resulting in up
to only a few thousand bases of DNA from a limited number
of sequences. Therefore, it is highly unlikely that enough
informative information could be gathered from one degrad-
ed archaeological sample to properly place an ancient bac-
terium into a phylogeographic type.
Recently introduced into the research field of aDNA stud-
ies, next generation sequencing (NGS) works by taking the
DNA and adding short sequences to either end that are com-
plimentary to universal primers, eliminating the specificity of
conventional PCR. Each piece of DNA is then amplified and
sequenced individually, so that thousands of strands can be
A. Bouwman : F. Rühli (*)
Centre for Evolutionary Medicine, Institute of Anatomy,
University of Zurich, Winterthurerstrasse 190,
8057 Zürich, Switzerland
e-mail: frank.ruhli@anatom.uzh.ch
Skeletal Radiol (2013) 42:751–752
DOI 10.1007/s00256-012-1568-1
analysed simultaneously (see Mardis [2] for an overview).
Therefore, the development of NGS systems allows for
thousands of targets and millions of bases to be sequenced at
once.
Using one of these NGS systems (SOLiD), MTBC DNA
from a 19th century British individual has been typed and
identified as a similar, but different type from that isolated in
North America in 1905, known as H37Rv [3]. One hundred
other individuals from the last 2,000 years across Europe are
still being analysed; the bone changes and strain identification
are being compared to see if there is any correlation between
the strain and the pathology.
Next-generation sequencing has opened up a new field of
research to the evolutionary medicine investigator and will
continue—alongside radiological diagnostics—to expand our
understanding of our past and present health.
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